The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Role of Complement and Complement Membrane Attack Complex in Laser-Induced Choroidal Neovascularization
Abstract
Choroidal neovascularization (CNV), or choroidal angiogenesis, is the hallmark of age-related macular degeneration and a leading cause of visual loss after age 55. The pathogenesis of new choroidal vessel formation is poorly understood. Although inflammation has been implicated in the development of CNV, the role of complement in CNV has not been explored experimentally. A reliable way to produce CNV in animals is to rupture Bruch’s membrane with laser photocoagulation. A murine model of laser-induced CNV in C57BL/6 mice revealed the deposition of C3 and membrane attack complex (MAC) in the neovascular complex. CNV was inhibited by complement depletion using cobra venom factor and did not develop in C3−/− mice. Anti-murine C6 Abs in C57BL/6 mice inhibited MAC formation and also resulted in the inhibition of CNV. Vascular endothelial growth factor, TGF-β2, and β-fibroblast growth factor were elevated in C57BL/6 mice after laser-induced CNV; complement depletion resulted in a marked reduction in the level of these angiogenic factors. Thus, activation of complement, specifically the formation of MAC, is essential for the development of laser- induced choroidal angiogenesis in mice. It is possible that a similar mechanism may be involved in the pathophysiology of other angiogenesis essential diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several experiments using mouse models of laser-induced CNV have demonstrated that all complement pathways, particularly the alternative and terminal pathways, play a significant role in angiogenesis [150,152,153,154,155,156,157,158,159,160,161,162,163].”
From Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration (2023) · cites this paper as [155]
Citations
Cites
Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy
Ferris, F. L., Fine, S., & Hyman, L. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040031330019 · Cited by 1,109
A role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Risk factors for age-related macular degeneration
Smith, W., Assink, J., Klein, R., Mitchell, P., Klaver, C. C. W., Klein, B. E. K., Hofman, A., Jensen, S., Wang, J. J., & de Jong, P. T. V. M. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00580-7 · Cited by 1,071
Pierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., & Smith, L. E. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.905 · Cited by 1,029
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Angiogenesis: regulators and clinical applications
Liekens, S., De Clercq, E., & Neyts, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00529-3 · Cited by 748
The codependence of angiogenesis and chronic inflammation
Jackson, J. R., Seed, M. P., Kircher, C. H., Willoughby, D. A., & Winkler, J. D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194526 · Cited by 692
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice
Ambati, J., Anand, A., Fernandez, S., Sakurai, E., Lynn, B. C., Kuziel, W. A., Rollins, B. J., & Ambati, B. K. (2003) · Nature Medicine · doi:10.1038/nm950 · Cited by 631
Krzystolik, M. G. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.3.338 · Cited by 591
The role of complement in inflammation and phagocytosis
Frank, M. M., & Fries, L. F. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90009-i · Cited by 505
Flagged first, then by citations
Research works printed but not linked: 51
- 1984, Arch. Ophthalmol., 1640
- 2000, N. Engl. J. Med., 483
- 2000, J. Cell. Physiol., 301
- 1995, Ophthalmology, 1380
- 2001, Ophthalmology, 697
- 1991, Arch. Ophthalmol., 1109
- 2001, Prog. Retinal Eye Res., 227
- 1999, Mol. Vis., 26
- 2002, Drugs Aging, 101
- 2002, Ophthalmol. Clin. North Am., 87
- 2000, J. Med. Genet., 83
- 1997, FASEB J., 457
- 1994, Invest. Ophthalmol. Vis. Sci., 3874
- 2001, Prog. Retinal Eye Res., 385
- 1997, Graefes Arch. Clin. Exp. Ophthalmol., 313
- 1995, Proc. Natl. Acad. Sci. USA, 905
- 2003, Invest. Ophthalmol. Vis. Sci., 3578
- 2003, Invest. Ophthalmol. Vis. Sci., 3586
- 2003, Nat. Med., 1390
- 1980, Clinical Immunology, 219
- 1991, Immunol. Today, 322
- 1993, Curr. Opin. Immunol., 83
- 1992, Curr. Top. Microbiol. Immunol., 115
- 1993, J. Clin. Invest., 1974
- 1994, J. Exp. Med., 985
- 1999, Am. J. Pathol., 1701
- 1990, Invest. Ophthalmol. Vis. Sci., 899
- 1995, Invest. Ophthalmol. Vis. Sci., 2110
- 1999, Nat. Med., 292
- 2003, Proc. Natl. Acad. Sci. USA, 2679
- 2003, Nat. Med., 206
- Invest. Ophthalmol. Vis. Sci., 3492
- 1961, Experimental Immunochemistry, 133
- 2001, Biochem. Pharm., 253
- 1999, Mol. Endocrinol., 806
- 1983, J. Exp. Med., 1885
- 2000, Proc. Natl. Acad. Sci. USA, 5450
- 2002, Invest. Opthalmol. Vis. Sci., 1104
- 1989, J. Immunol., 2654
- 1995, Proc. Natl. Acad. Sci. USA, 8955
- 1996, Proc. Natl. Acad. Sci. USA, 8563
- 1994, Invest. Opthalmol. Vis. Sci., 3178
- 1996, Curr. Eye Res., 1008
- 1996, Jpn. J. Ophthalmol., 329
- 1997, Curr. Eye Res., 9
- 2000, Invest. Ophthalmol. Vis. Sci., 3158
- 2002, Arch. Ophthalmol., 338
- 2000, Exp. Eye Res., 441
- 2000, FASEB J., 835
- 2002, Am. J. Ophthalmol., 411
- 1998, Arch. Ophthalmol., 1629
Cited by
Sorted by citations
Vascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 784
Para-Inflammation in the Aging Retina
Xu, H., Chen, M., & Forrester, J. V. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.06.001 · Cited by 659
Drusen complement components C3a and C5a promote choroidal neovascularization
Nozaki, M., Raisler, B. J., Sakurai, E., Sarma, J. V., Barnum, S. R., Lambris, J. D., Chen, Y., Zhang, K., Ambati, B. K., Baffi, J. Z., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408835103 · Cited by 650
Girardi, G., Yarilin, D. A., Thurman, J. M., Holers, V. M., & Salmon, J. E. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061022 · Cited by 509
Angiogenesis and chronic inflammation: cause or consequence?
Costa, C., Incio, J., & Soares, R. A. (2007) · Angiogenesis · doi:10.1007/s10456-007-9074-0 · Cited by 510
Metadata
- Authors
- Bora, P. S., Sohn, J.-H., Cruz, J. M. C., Jha, P., Nishihori, H., Wang, Y., Kaliappan, S., Kaplan, H. J., & Bora, N. S.
- Affiliations
- University of Louisville (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-01-01
- Volume
- 174
- Issue
- 1
- Pages
- 491-497
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1901360874
- Cited by
- 249
- References
- 48
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 10 · 2023: 9 · 2022: 6 · 2021: 11 · 2020: 13 · 2019: 6 · 2018: 7 · 2017: 11 · 2016: 6 · 2015: 13 · 2014: 15 · 2013: 8 · 2012: 15
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r01ey009730-07)
- National Eye Institute (R01 EY009730-07, R01EY013335, R01EY014623, EY 014623, EY-13335)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- choroidal neovascularization, complement system, membrane attack complex, choroidal angiogenesis, age-related macular degeneration, laser photocoagulation, Bruch's membrane rupture, complement C3, complement depletion, cobra venom factor, vascular endothelial growth factor, TGF-beta2, basic fibroblast growth factor, angiogenic factors, mouse model
- MeSH terms
- Animals, Choroid, Complement Activation, Complement C3, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Fibroblast Growth Factors, Immunohistochemistry, Lasers, Male, Complement Membrane Attack Complex, Transforming Growth Factor beta, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction, Choroidal Neovascularization, Vascular Endothelial Growth Factor A, Mice, Transforming Growth Factor beta2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
